11 October 2017: ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, presents positive pre-clinical data with its ExoPr0 exosome cancer therapy candidate at major scientific conference.
11 October 2017: ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, presents positive pre-clinical data with its ExoPr0 exosome cancer therapy candidate at major scientific conference.